Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report

Background: Positron emission tomography (PET)/computed tomography (CT) simulation in cervical cancer may help radiation oncologists to better define the target volumes. It may also detect extrapelvic lesions and incidental second malignancies, leading to significant changes in treatment management. Case: A 63-year-old woman who was deemed inoperable due to carcinoma of the cervical stump extending to the parametria and paraaortic lymph nodes detected on MR images presented for extended field radiotherapy. PET/CT simulation revealed an FDG avid mass in the cervical stump, and an enlarged axillary lymphadenopathy showing moderate FDG uptake. The excisional biopsy was consistent with small lymphocytic lymphoma (SLL). Conclusion: In our case, PET/CT simulation not only led to changes in treatment management, but also revealed a very rare coexistence of SLL and invasive squamous cell carcinoma of the cervix.

PET/CT/simulation; SLL; Uterine cervix

[1] Mikami Y., Maehata K., Fujiwara K., Sasano H.: “Squamous cell carcinoma of the uterine cervix in association with stage 0 chronic lymphocytic leukemia/small lymphocytic lymphoma”. Gynecol. Oncol., 2004, 92, 974.

[2] Öksüz D.Ç., S¸ahinler I·., Atkovar G., Ferhanog˘lu B, Okkan S.: “Synchronous endometrium cancer and chronic lymphocytic leukemia: a case report” (in Turkish). Türk. Onkoloji Dergisi, 2003, 18, 118.

[3] Gregoire V., Haustermans K., Geets X., Roels S, Lonneux M.: “PET based treatment planning in radiotherapy: A new standard?”. J. Nucl. Med., 2007, 48, 68S.

[4] Brown M.A., Kubik-Huch R.A., Reinhold C., Semelka R.C.: “Uterus and Cervix”. In: Semelka R.C. (ed.). Abdominal-Pelvic MRI, second edition. New Jersey: John Wiley and Sons, Inc., 2006, 1251.

[5] Smith T.: “FDG uptake, tumor characteristics, and response to therapy: A review”. Nucl. Med. Commun., 1998, 19, 97.

[6] Rohren E.M., Turkington T.G., Coleman R.E.: “Clinical application of PET in oncology”. Radiology, 2004, 231, 305.

[7] Grigsby P.W., Siegel B.A., Dehadashti F.: “Lymph node staging by positron emission tomography in patients with carcinoma of the cervix”. J. Clin. Oncol., 2001, 19, 3745.

[8] Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., Ihling C., Högerle C., Mix M. et al.: “Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET”. Radiology, 2001, 218, 776.

[9] Sugawara Y., Eisbruch A., Kosuda S., Recker B.E., Kison P.V., Wahl R.L.: “Evaluation of FDG PET in patients with cervical cancer”. J. Nucl. Med., 1999, 40, 1125.

[10] Najjar F., Hustinx R., Jerusalem G., Filet G., Rigo P.: “PET for staging low grade NHL”. Cancer Biother Radiopharm., 2001, 16, 297.

[11] Jerusalem G., Beguin Y., Najjar F., Hustinx R., Fassotte M.F., Rigo P. et al.: “Positron emission tomography (PET) with 18F-Fluorodeoxyglucose (18F-FDG) fort he staging of low grade non- Hodgkin’s lymphoma (NHL)”. Ann. Oncol., 2001, 12, 825.